HRT Financial
BNTX icon

HRT Financial’s BioNTech BNTX Stock Holding History

HRT Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,200
Closed -$1.86M – 3127
2021
Q4 		$1.86M Buy
7,200
+2,400
+50% +$657K 0.01% 705
2021
Q3 		$1.31M Buy
4,800
+2,400
+100% +$763K 0.01% 1046
2021
Q2 		$537K Buy
+2,400
New +$453K ﹤0.01% 1700

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

HRT Financial's BNTX Position: Q2 2026 in Review

HRT Financial opened a new position in BioNTech (BNTX) in Q2 2026: 58,648 shares worth $5.46M. The stake represents 0.01% of the portfolio and ranks #1101 among its holdings. This is a return to the name: HRT Financial previously reported a position in BNTX as recently as Q4 2025.

HRT Financial first reported a position in BNTX in Q2 2022 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • HRT Financial held 58,648 shares of BioNTech worth $5.46M as of Q2 2026.
  • BioNTech was a new HRT Financial position in Q2 2026.
  • BioNTech made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1101 holding.
  • HRT Financial first reported a position in BioNTech in Q2 2022 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.